Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404855 · ClinicalTrials.gov registry record · NA
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT04404855 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 240 participants.
The verdict
NCT04404855, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.
Interventions
- OTHER NGS + Antibiotic Recommendation
- PROCEDURE Standard of Care treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2019-12-18 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04404855
The ClinicalTrials.gov registry entry for NCT04404855 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NGS + Antibiotic Recommendation is the first listed.
NCT04404855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04404855 about?
NCT04404855 is a clinical study titled "Antibiotic Selection Using Next Generation Sequencing vs Urine Culture". This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.
What is the current status of trial NCT04404855?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2019-12-18. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT04404855?
The interventions under investigation include: NGS + Antibiotic Recommendation (OTHER), Standard of Care treatment (PROCEDURE).
Who is sponsoring clinical trial NCT04404855?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.